Back to Search
Start Over
Botulinum toxin type A for genitofemoral neuralgia: A case report.
- Source :
-
Frontiers in neurology [Front Neurol] 2023 Jul 03; Vol. 14, pp. 1228098. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Tereshko, Enrico, Christian, Dal Bello, Merlino, Gigli and Valente.)
Details
- Language :
- English
- ISSN :
- 1664-2295
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in neurology
- Publication Type :
- Academic Journal
- Accession number :
- 37465764
- Full Text :
- https://doi.org/10.3389/fneur.2023.1228098